CD5+ B cells in myasthenia gravis. Clinical correlations.
Ragheb
S
S
Department of Neurology, Wayne State University, Detroit, Michigan 48201.
Lisak
R P
RP
D000328:Adult; D000367:Age Factors; D015703:Antigens, CD / Q000032:analysis*; D016175:B-Lymphocyte Subsets / Q000276:immunology*; D018956:CD5 Antigens; D005455:Fluorescent Antibody Technique; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000276:immunology*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012016:Reference Values; D013601:T-Lymphocytes / Q000276:immunology
D015703:Antigens, CD; D018956:CD5 Antigens; D007166:Immunosuppressive Agents; D011729:Pyridostigmine Bromide